BACE1-IN-14

BACE1-IN-14 (compound 27f) is a BACE1 inhibitor, with the EC50 values of 0.7 μM and 1.6 μM for BACE1 and BACE2. BACE1-IN-14 is can be used in Alzheimer's disease (AD) research[1].

Product Specifications

UNSPSC

12352005

Target

Beta-secretase

Type

Reference compound

Related Pathways

Neuronal Signaling

Applications

Neuroscience-Neurodegeneration

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/bace1-in-14.html

Solubility

10 mM in DMSO

Smiles

FC1=CC(NC(NC2=C(COC3=CC=C(C4=CC=CC=C4)C=C3)C=CC=C2)=N5)=C5C=C1

Molecular Formula

C26H20FN3O

Molecular Weight

409.45

References & Citations

[1]Quang De T, et al. Rational design of novel diaryl ether-linked benzimidazole derivatives as potent and selective BACE1 inhibitors. Biochem Biophys Res Commun. 2024 Feb 26;698:149538.